Showing results (261-270 of 344) with videos related to
Sort By:
Pageof 35
Hepatology (Baltimore, Md.)|September 12, 2015
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis BCarolina Boni, Pietro Lampertico, Lavinia Talamona, et al.Hepatology (Baltimore, Md.)|February 28, 2007
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective studySavino Bruno, Tommaso Stroffolini, Massimo Colombo, et al.Annals of Internal Medicine|November 15, 2016
Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized TrialMassimo Colombo, Alessio Aghemo, Hong Liu, et al.Plos One|September 24, 2015
Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or CirrhosisAntonia Lepida, Massimo Colombo, Inmaculada Fernandez, et al.Hepatology (Baltimore, Md.)|April 27, 2011
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Valentina Fabbris, et al.Journal of Hepatology|February 24, 2009
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinomaLuca Di Tommaso, Annarita Destro, Jae Yeon Seok, et al.Journal of Hepatology|February 15, 2011
Management of hepatitis C virus genotype 4: recommendations of an international expert panelMahmoud A Khattab, Peter Ferenci, Stephanos J Hadziyannis, et al.Gut|August 4, 2012
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis BPietro Lampertico, Mauro Viganò, Giovan Giuseppe Di Costanzo, et al.Alimentary Pharmacology & Therapeutics|November 21, 2024
Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAAGian Paolo Caviglia, Piero Fariselli, Roberta D'Ambrosio, et al.Journal of Hepatology|January 17, 2012
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2aVincent Rijckborst, Bettina E Hansen, Peter Ferenci, et al.Pageof 35